Janina Auth

553 total citations
11 papers, 225 citations indexed

About

Janina Auth is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, Janina Auth has authored 11 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Janina Auth's work include SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (2 papers) and COVID-19 Clinical Research Studies (2 papers). Janina Auth is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (2 papers) and COVID-19 Clinical Research Studies (2 papers). Janina Auth collaborates with scholars based in Germany, United Kingdom and United States. Janina Auth's co-authors include Ulrich S. Schubert, Martina Morokutti-Kurz, Philipp Graf, Eva Prieschl‐Grassauer, Andreas Grassauer, Pia Rauch, Michael Schindler, Natalia Ruétalo, Ramona Businger and Dan Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Janina Auth

10 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janina Auth Germany 7 70 55 41 28 22 11 225
Martina Morokutti-Kurz Germany 9 58 0.8× 116 2.1× 65 1.6× 36 1.3× 34 1.5× 12 328
Krylova Nv Russia 10 68 1.0× 141 2.6× 65 1.6× 29 1.0× 23 1.0× 55 396
José A. Aguilar-Briseño United States 7 111 1.6× 112 2.0× 60 1.5× 58 2.1× 13 0.6× 11 306
Yinzhi Lang United States 11 32 0.5× 120 2.2× 85 2.1× 8 0.3× 20 0.9× 24 331
Mohamed G. Seadawy Egypt 8 57 0.8× 12 0.2× 58 1.4× 7 0.3× 21 1.0× 28 218
Paweł Botwina Poland 8 69 1.0× 9 0.2× 51 1.2× 22 0.8× 9 0.4× 14 220
Jiajing Li China 10 38 0.5× 12 0.2× 92 2.2× 25 0.9× 12 0.5× 23 274
Xu Dong China 9 22 0.3× 12 0.2× 117 2.9× 36 1.3× 26 1.2× 17 283
Mario A. Peña-Hernández United States 5 161 2.3× 65 1.2× 66 1.6× 78 2.8× 19 0.9× 6 329

Countries citing papers authored by Janina Auth

Since Specialization
Citations

This map shows the geographic impact of Janina Auth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janina Auth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janina Auth more than expected).

Fields of papers citing papers by Janina Auth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janina Auth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janina Auth. The network helps show where Janina Auth may publish in the future.

Co-authorship network of co-authors of Janina Auth

This figure shows the co-authorship network connecting the top 25 collaborators of Janina Auth. A scholar is included among the top collaborators of Janina Auth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janina Auth. Janina Auth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Garantziotis, Panagiotis, Janina Auth, G. Schett, & Christina Bergmann. (2025). CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation. Current Opinion in Rheumatology. 38(1). 60–68.
2.
Auth, Janina, et al.. (2023). Emergency scrotal exploration in children: Following a change in mindset in the UK. Journal of Pediatric Urology. 19(4). 474–476. 3 indexed citations
3.
Rauch, Pia, et al.. (2023). European Black Elderberry Fruit Extract Inhibits Replication of SARS-CoV-2 In Vitro. SHILAP Revista de lepidopterología. 3(1). 91–106. 6 indexed citations
4.
Auth, Janina, Pia Rauch, Alexandra Herrmann, et al.. (2023). Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5. SHILAP Revista de lepidopterología. 3(3). 315–328. 6 indexed citations
6.
Auth, Janina, et al.. (2022). Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. International Journal of Molecular Sciences. 23(12). 6830–6830. 7 indexed citations
7.
Morokutti-Kurz, Martina, Philipp Graf, Andreas Grassauer, et al.. (2021). Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. PLoS ONE. 16(2). e0237480–e0237480. 86 indexed citations
8.
Auth, Janina, Pia Rauch, Natalia Ruétalo, et al.. (2021). Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta. International Journal of Molecular Sciences. 22(19). 10205–10205. 25 indexed citations
9.
Ruétalo, Natalia, Dan Hu, Ramona Businger, et al.. (2021). Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. Viruses. 13(4). 647–647. 37 indexed citations
10.
Rauch, Pia, Janina Auth, Jan Münch, et al.. (2021). Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta. International Journal of Molecular Sciences. 22(24). 13202–13202. 33 indexed citations
11.
Ruétalo, Natalia, Ramona Businger, Pia Rauch, et al.. (2020). Evidence That Quinine Exhibits Antiviral Activity against SARS-CoV-2 Infection In Vitro. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026